“CC#139511: A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma June 15, 2017 Sponsor University of California and San Francisco Protocol Number UCSF 139511 To Learn More Call (201)-510-0950
